Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors

Thrombosis and Haemostasis

Volumn 96, Issue 5, 2006, Pages 590-596

  Kitchen, Stephen ^a   Kitchen, Dianne P ^a   Jennings, Ian ^a   Woods, Tim A L ^a   Walker, Isobel D ^a   Preston, F Eric ^a  

^a UK NEQAS for Blood Coagulation   (United Kingdom)

Author keywords

INR; NPT POC; Proficiency testing

Indexed keywords

ANALYTIC METHOD; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; BLOOD SAMPLING; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; HEALTH SURVEY; HOSPITAL LABORATORY; HUMAN; INTERNATIONAL NORMALIZED RATIO; MONITOR; POINT OF CARE TESTING; PRIORITY JOURNAL; QUALITY CONTROL; UNITED KINGDOM;

CALIBRATION; GREAT BRITAIN; HUMANS; INTERNATIONAL NORMALIZED RATIO; LABORATORIES, HOSPITAL; POINT-OF-CARE SYSTEMS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 33751258588     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-01-0031     Document Type: Article

References (29)

1. Loeliger EA, Van den Besselaar AMHP, Broekmans AW. Intensity of oral anticoagulation in patients monitored with various thromboplastins. New Engl J Med 1983; 308: 1228-9.
2. Denson KWE. Thromboplastin- sensitivity, precision, and other characteristics. Clin Lab Haem 1988; 10: 315-28.
3. Jackson CM, Esnouf MP, Lindahl TL. A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy. Pathophysiol Haemost Thromb 2003; 33: 43-51.
4. Horsti J. Has the Quick or the Owren prothrombin time method the advantage in harmonisation of the international sensitiviy index correction? Clin Chem 2001; 47: 940-4.
5. Horsti J. The quick and Owren Prothrombin time methods for oral anticoagulant therapy do not agree well using the INR units. Scand J Clin Lab Invest 2003; 63: 455-6.
6. Loeliger EA, Vanden Besselaar AMHP, Lewis SM. Reliability and clinical impact for the normalisation of the prothrombin time. Thromb Haemost 1985; 53: 148-54.
7. Bussey HI, Force FW, Bianco TM, et al. Reliance on PT ratio causes significant error in anticoagulant therapy. Arch Intern Med 1992; 152: 278-82.
8. Hirsh. J. Substandard monitoring of warfarin in North America: time for change. Arch Int Med 1992; 152: 257-8.
9. Eckman MH, Levine HJ, Pauker SG. Effect of laboratory uncertainty in the prothrombin time ratio on the results of oral anticoagulant therapy. N Eng J Med 1993; 329: 696-702.
10. Kitchen S, Jennings I, Woods TAL, et al. Two recombinant tissue factor reagents compared to conventional thromboplastins for determination of INR: A 33 laboratory collaborative study. Thromb Haemost 1996; 76: 372-6.
11. Tripodi A, Arbin AA, Chantarangkul V et al. Are capillary whole blood monitors suitable for the control of oral anticoagulant therapy by the INR? Thromb Haemost 1993; 70: 921-4.
12. Van den Besselaar AMHP, Breddin K, Lutze G, et al. Multicenter evaluation of a new capillary blood prothrombin time monitoring system. Blood Coag Fibrinol 1995; 6: 726-32.
13. Hasenkam JM, Kinose HH, Knudsen L, et al. Self management of oral anticoagulant therapy after heart valve replacement. Eur J Cardio-Thor Surg 1997; 11: 935-42.
14. Van Dijk-Wierda CA, van Halem-Visser R, van der Hoeff-van Halem, et al. The preparation of control assessment programs in oral anticoagulant control. Thromb Haemost 1978; 39: 210-4.
15. Lang H, Scheer B, Moritz B, et al. International Normalised ratio - proficiency tests by OQUASTRA for the prothrombin time. Hamostaseologie 1995; 15: 41-8.
16. Houbouyan LL, Goguel AF. Long-term French experience in INR standardisation by a procedure using plasma calibrants. Am J Clin Pathol 1997; 108: 83-9.
17. Brien WF, Crawford L, Wood DE. Discrepant results in INR testing. Thromb Haemost 1994; 72: 986-7.
18. Cunningham MT, Praestgaard J, Styer PE, et al. A method for proficiency testing of small peer groups in the College of American Pathologists Coagulation Surveys. Arch Pathol Lab Med 1999; 123: 199-205.
19. England JM, Hyde K, Lewis SM, et al. Guidelines for near patient testing: Haematology. Clin Lab Haem 1995; 17: 301-10.
20. Medical Devices Agency device Bulletin MDA DB2002(03) March 2002, Medical Devices Agency of UK Department of Health, Hannibel House, Elephant and Castle, London, SE1 6TQ.
21. Jennings I, Kitchen S, Woods TAL, et al. EQA of near patient test instruments. Thromb Haemost 1997; (Suppl 1): 704.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical assessment. Lancet 1986; i: 307-10.
23. Marzinotto V, Mongale P, Chan A, et al. Capillary whole blood monitoring of Ooal anticoagulants in children in outpatient clinics and the home setting. Pediatr Cardiol 2000; 21: 347-52.
24. Poller L, Keown M, Chauhan N, et al. European Concerted Action on Anticoagulation. Use of plasma samples to derive International Sensitivity Index for whole-blood prothrombin time monitors. Clin Chem 2002; 48: 255-60.
25. Horsti J. Agreement of Owren and Quick prothrombin Times: Effect of citrate and calcium concentrations and International Sensitivity Index correction. Clin Chem 2001; 47: 940-4.
26. Kitchen S, Jennings I, Woods TAL, et al. Local calibration of INR improves between laboratory agreement: results from the UK NEQAS. Thromb Haemost 1999; 81: 60-5.
27. Van den Besselaar AMHP. A comparison of INRs determined with a whole blood prothrombin time device and two International Reference preparations for thromboplastin. Thromb Haemost 2000; 84: 410-2.
28. Poller L, Van den Besselaar AMHP, Jespersen J, et al. The effect of sample size on fresh plasma ISI determinations. Br J Haematol 1999; 105: 655-63.
29. Murray ET, Kitchen DP, Kitchen S, et al. Patient Self-management of oral anticoagulation and external quality assessment procedures. Br J Haematol 2003; 122: 825-8.